INTRODUCTION
Protein synthesis is a complex process that can generate faulty proteins with cytotoxic properties (Brandman and Hegde, 2016; Pechmann et al., 2013) . Cells have evolved complex machinery for ribosomal quality control (RQC) to clear aberrant translation products that undergo ribosome stalling (Brandman and Hegde, 2016) . The RQC pathway has mainly been studied with proteins that remain in the cytosol, but proteins that must be delivered to membrane-bound organelles or secreted to the exterior may also undergo stalling when translated from faulty mRNAs. An unresolved question concerns the RQC mechanism for proteins that are imported into the mitochondria (Neupert, 2015; Topf et al., 2016; Wiedemann and Pfanner, 2017) , a collective of about 1,000 proteins in S. cerevisiae and 1,500 proteins in mammalian cells (Sickmann et al., 2003) . In principle, there are two systems that can clear aberrant mitochondrial proteins that are stalled on cytosolic ribosomes, the RQC that acts prior to import and the mitochondrial chaperone and protease network that acts following import (Quiró s et al., 2015) .
Ribosome stalling may be caused by the lack of a stop codon in the mRNA, by mRNA truncation, the presence of stable secondary structure in the mRNA or by an insufficient supply of charged tRNAs (Brandman and Hegde, 2016) . Stalling activates machinery that mediates dissociation of the 80S ribosome, and the subsequent retention of the peptidyl-tRNA by the 60S subunit. These 60S ribosome-nascent peptide complexes are recognized by the RQC components Rqc2 and the E3 ubiquitin ligase Ltn1 (Brandman et al., 2012; Defenouillè re et al., 2013; Lyumkis et al., 2014; Shao et al., 2013 Shao et al., , 2015 . Rqc2 is required for efficient recruitment of Ltn1 to the 60S ribosome for ubiquitylation of the nascent peptide. Extraction of the ubiquitylated chain from the ribosome for proteasomal degradation is then facilitated by Rqc1 acting in conjunction with Cdc48 and Npl4/Ufd1 (Brandman and Hegde, 2016) . In addition to recruiting Ltn1, Rqc2 modifies the stalled nascent chains by the C-terminal addition of variable length sequences consisting of alanyl and threonyl residues (so-called CAT-tails) (Shen et al., 2015) . As shown in yeast cells, when ubiquitylation of stalled chains is compromised, stalled polypeptides nevertheless dissociate from the 60S ribosome and form detergent-stable aggregates in the cytosol (Choe et al., 2016; Defenouillè re et al., 2016; Yonashiro et al., 2016) . Aggregation is dependent on the CAT-tail sequences and causes the sequestration of cytosolic chaperones. A functional deficiency of Ltn1 is associated with age-dependent neurodegeneration in a mouse model (Chu et al., 2009) .
We reasoned that the clearance of ribosome-stalled proteins with N-terminal targeting sequences for the mitochondria would be confounded by the problem that protein import can initiate co-translationally (Williams et al., 2014) . As a result, stalled ribosomes may directly contact the mitochondrial translocation channel (Izawa et al., 2012) , rendering the nascent chain partly or completely inaccessible to ubiquitylation and the cytosolic degradation machinery.
Here, we have studied the potential role of the cytosolic protein Vms1 in the ribosome quality-control pathway for stalled mitochondrial polypeptides. Vms1 is a 73kDa multi-domain protein that interacts with Cdc48 at the mitochondria upon oxidative stress and also at the endoplasmic reticulum (Heo et al., 2010; Tran et al., 2011) . Deletion of VMS1 causes respiratory dysfunction and a defect in colony formation of yeast cells that have reached stationary phase (Heo et al., 2010) . Moreover, VMS1 deletion results in impaired growth in cells defective in exosome-mediated mRNA degradation (Defenouillè re et al., 2013) . We report now that Vms1 is a 60S ribosome-binding protein and a key component of a ribosome quality-control pathway for mitochondrial polypeptides (mitoRQC) that acts in concert with Ltn1 and Rqc2. Combined deletion of VMS1 and LTN1 results in a severe synthetic growth defect under respiratory conditions caused by the aggregation of CAT-tailed proteins in the mitochondria. Importantly, Vms1 acts to suppress this toxic effect by counteracting CAT tailing of ribosome-stalled polypeptides by Rqc2, thereby facilitating import, diminishing CAT-taildependent aggregation and directing aberrant polypeptides to intra-mitochondrial quality control. Our results may help to explain how defective ribosome quality control leads to neurodegeneration.
A C B Figure 1. Vms1 Associates with 60S Ribosomes and the RQC Complex
(A) Cell lysates of vms1D cells expressing Vms1-3HA or Vms1-3Myc from the GPD1 promoter were subjected to anti-Myc immunoprecipitation. Precipitates were analyzed by SDS-PAGE, Coomassie blue staining, and mass spectrometry (MS). Asterisks, immunoglobulin heavy and light chains. (B) Volcano plot of the proteins co-precipitated with Vms1-3Myc and identified by label-free proteomics. p values and fold enrichment are shown.
Proteins of interest are highlighted (see Table S1 and STAR Methods). (C) Recovery of 60S and 40S ribosomal proteins by MS analysis as in (A) . Median values from labelfree quantification (LFQ) of the recovered ribosomal proteins are shown. See also Figure S1 .
RESULTS

Vms1 Associates with 60S Ribosomes and the RQC Complex
In order to study the role of Vms1 in mitochondrial homeostasis, we overexpressed C-terminally Myc-tagged Vms1 in a vms1 deletion strain and performed a Vms1 interactome analysis. The antiMyc antibody precipitated Vms1-3Myc and numerous other proteins from cell lysates (Figures 1A and 1B) . Cells expressing C-terminally HA-tagged Vms1 served as control. Analysis of the Vms1 precipitate by quantitative mass spectrometry (MS) identified nearly all 60S ribosomal proteins; 40S ribosomal proteins were detected to a much lesser extent (Figures 1B and 1C; Table S1 ). Interestingly, Ltn1 and Rqc2, key components of the RQC system, as well as Cdc48, Npl4, and Ufd1 also co-precipitated with Vms1-3Myc ( Figure 1B ; Table S1 ). To confirm the interaction of Vms1 with 60S ribosomes, lysates were prepared from cells expressing Vms1-3Myc from the endogenous VMS1 promoter and subjected to sucrose gradient centrifugation (Figure S1) . Vms1 was strongly enriched in the 60S ribosome fraction. These results demonstrate that Vms1 associates with 60S ribosomes that have engaged the RQC system.
Vms1 and Ltn1 Are Required for Maintenance of Respiratory Function
Given its proposed function in protecting mitochondria under stress conditions, we considered the possibility that Vms1 and the RQC machinery cooperate in maintaining mitochondrial protein homeostasis. Wild-type (WT) cells and the mutant strains vms1D, ltn1D, and vms1Dltn1D were grown on fermenting (YPD) or on respiratory medium (YPG) at 23 C-37 C ( Figure 2A ). Vms1D and ltn1D cells did not show a growth defect, but the vms1Dltn1D double deletion strain displayed reduced growth on YPD, in particular, at higher temperature. Under respiratory conditions on YPG, vms1Dltn1D cells grew moderately slower than on YPD at 23 C and 30 C, and a strong growth defect was observed at 37 C ( Figure 2A ). In contrast, the rqc1D, rqc2D, vms1Drqc1D, and vms1Drqc2D strains showed no growth defect ( Figure S2A ). These results suggested that Vms1 and Ltn1 act in preventing mitochondrial damage by aberrant proteins that are continually produced, even in the absence of overt stress. Such damage may be critical under respiratory conditions when large amounts of mitochondrial proteins are synthesized for oxidative phosphorylation (OXPHOS) and production of reactive oxygen radicals is increased.
The surprising finding that the combined deletion of two cytosolic proteins, Vms1 and the RQC component Ltn1, severely impaired growth under respiratory conditions suggested that aberrant proteins accumulate in vms1Dltn1D cells, overwhelming mitochondrial quality control. In order to further explore the role of Vms1 and Ltn1 in maintaining mitochondrial function, we determined the levels of OXPHOS proteins in the deletion strains ( Figure 2B ). Deletion of either Vms1 or Ltn1 individually did not affect the levels of the subunits of respiratory complexes or the F 1 F o -ATP synthase. However, in the vms1Dltn1D double mutant, the levels of the mitochondrially encoded cytochrome b of complex III and subunit 2 of cytochrome oxidase (complex IV), as well as the nuclear encoded F 1 b subunit of F 1 F o -ATP synthase were markedly reduced. Components of the mitochondrial import machinery (Tom40, Tim50, Tim23, Mia40) and proteins determining mitochondrial structure (Mic60, Yme1) did not change in abundance, arguing against a general defect in mitochondrial biogenesis. Interestingly, the mature form of the Rieske iron sulfur protein of complex III, Figures 2B and 2C ). The levels of RIP1 mRNA in mutant cells were similar to WT ( Figure S2B ). i-Rip1 is generated by cleavage of the targeting sequence in the mitochondrial matrix (Figure S2C ) (Hartl et al., 1986) . Processing to the mature form occurs after the chaperone-mediated insertion of the Fe/S cluster and assembly into complex III (Conte and Zara, 2011) . The accumulation of i-Rip1 in vms1Dltn1D cells may thus reflect a defect in chaperone-dependent Fe/S cluster formation (Wagener et al., 2011) . These observations suggested that respiratory supercomplexes were affected in vms1Dltn1D mutant cells. Indeed, analysis of mitochondrial lysates by blue native PAGE showed that supercomplexes III 2 +IV 2 and III 2 +IV, consisting of respiratory complexes III and IV in different molar ratios, were strongly diminished ( Figure 2D , left). Likewise, the level of the F 1 F o -ATP synthase (complex V) was considerably reduced ( Figure 2D , right). In summary, in the absence of Vms1 and Ltn1, the OX-PHOS system of mitochondria is severely impaired, consistent with the growth defect of vms1Dltn1D cells under respiratory conditions.
Loss of Vms1 and Ltn1 Leads to Rqc2-Dependent Aggregation of Mitochondrial Proteins
We next investigated the potential role of Rqc1 and Rqc2 in maintaining respiratory competence in conjunction with Vms1 and Ltn1. Toward this end, we constructed vms1Dltn1Drqc1D and vms1Dltn1Drqc2D triple mutants. Vms1Dltn1Drqc1D cells showed the same growth deficiency as vms1Dltn1D cells (Figure 3A) . Strikingly, the additional deletion of RQC2 almost completely rescued the growth defect of vms1Dltn1D cells on respiratory medium ( Figure 3A) .
Recent studies have shown that stalled nascent chains can form cytosolic aggregates in ltn1D cells in a manner dependent on Rqc2-mediated CAT tailing and that these aggregates sequester the chaperone Sis1 and multiple cytosolic proteins (Choe et al., 2016) . We therefore hypothesized that the respiratory defect of vms1Dltn1D cells may be caused by the aggregation of aberrant mitochondrial proteins that are otherwise removed by the RQC. To test this, we analyzed detergent insoluble protein aggregates in vms1Dltn1D cells by centrifugation of cell lysates, followed by immunoblotting with antibodies against Rip1 and the mitochondrial chaperones Hsp60, mtHsp70 (Ssc1), and Ssq1, the latter being required for Fe/S cluster formation (Craig et al., 1999) . In vms1Dltn1D cells, Rip1 accumulated exclusively in the insoluble fraction as i-Rip1, indicating that aggregation occurred after import into the mitochondria ( Figure 3B ). The chaperone proteins also aggregated, with Ssq1 being most enriched in the insoluble fraction ( Figure 3B ). Aggregation was apparently restricted to mitochondrial proteins, as cytosolic phosphoglycerate kinase (Pgk1), the cytosolic Hsp70 homolog Ssa1, and the ER chaperone BiP (Kar2) remained soluble (Figure S3) . In contrast to the vms1Dltn1D strain, WT, vms1D, and ltn1D strains did not accumulate significant amounts of mitochondrial protein aggregates ( Figure 3B ). Remarkably, essentially no aggregates of mitochondrial proteins were detected in vms1Dltn1Drqc2D cells and Rip1 was processed normally ( Figure 3B ), pointing to CAT-tailed proteins as the driver of aggregation and the Rip1 processing defect. Indeed, i-Rip1 accumulated when vms1Dltn1Drqc2D cells were transformed with WT RQC2 (Figure 3C ). In contrast, upon expression of rqc2-aaa, a mutant unable to synthesize CAT tails (Shen et al., 2015) , i-Rip1 was processed to the mature form ( Figure 3C) .
We next employed quantitative proteomics by stable isotope labeling using amino acids in cell culture (SILAC) (Ong et al., 2002) to globally assess the extent of protein aggregation in vms1Dltn1D cells and the effect of additional RQC2 deletion. Ltn1D cells served as the reference strain ( Figure 3D ). Out of the 107 proteins that were significantly enriched in the detergent insoluble fraction of vms1Dltn1D cells, 101 were mitochondrial proteins ( Figure 3E and Table S2A ). Only six proteins from other cellular compartments were found to aggregate, possibly representing contaminants. Thus, the defect of vms1Dltn1D cells is specific to mitochondria. In contrast, vms1Dltn1Drqc2D cells showed no significant increase in insoluble mitochondrial proteins ( Figure 3E ; Table S2B ). The insoluble proteins in the vms1Dltn1D mutant are either localized in the mitochondrial matrix or move through the matrix during intra-mitochondrial sorting, including multiple subunits of the F 1 F o -ATP synthase, subunits of respiratory chain complexes (including Rip1) and chaperones (Hsp60, mtHsp70, Ssq1, Mge1) ( Figure 3F ; Table S2A ). Interestingly, numerous mitochondrial ribosomal proteins and tRNA ligases were also identified in the insoluble fraction ( Figure 3F ), suggesting that vms1Dltn1D cells are defective in mitochondrial translation, consistent with the reduced levels of cytochrome b and cytochrome oxidase subunit 2 (Cox2) ( Figure 2B ).
Taken together, these results suggest that yeast cells constantly produce substantial amounts of aberrant mitochondrial proteins. Such proteins accumulate to toxic levels in respiring mitochondria of vms1Dltn1D cells, resulting in a general loss of mitochondrial protein homeostasis. This toxic effect is apparently mediated by the CAT-tails that are added to ribosome-stalled chains by Rqc2.
Vms1 Functions in RQC for Mitochondrial Proteins
Proteins encoded by mRNAs lacking a stop codon carry a C-terminal poly-lysine sequence that results from the partial translation of the mRNA poly(A) tail. This poly-lysine sequence, directly or indirectly, causes stalling of the non-stop (NS) protein in the ribosomal exit tunnel (Brandman and Hegde, 2016) . We constructed NS-GFP proteins that remain in the cytosol (NS-cGFP) or are targeted to the mitochondria via the N-terminal targeting sequence of F o -ATPase subunit 9 (NS-mtGFP) ( Figure 4A ). Upon inducible overexpression from a GAL1 promoter for 20 hr, WT cells accumulated only low amounts of these proteins, indicating efficient clearance ( Figure 4B ). As expected, the NS proteins accumulated in ltn1D cells and also formed SDS-resistant high-molecular-weight species. This high-molecular-weight protein was not ubiquitylated and represented aggregated NS protein ( Figure S4A ) (Choe et al., 2016) . NS-mtGFP aggregation was strongly enhanced compared to NS-cGFP, with the majority of mitochondrial NS protein migrating at the top of the gel ( Figure 4B ). Aggregates were absent in rqc2D cells and in ltn1Drqc2D cells ( Figure 4C ). The NS-mtGFP formed fluorescent inclusions in ltn1D cells that colocalized with the mitochondria ( Figure S4B ). Inclusions were markedly reduced upon deletion of RQC2 ( Figure S4B ). Additional evidence for the role of CAT tails as drivers of aggregation was provided by the demonstration that mtGFP carrying an artificial CAT tail (mtGFP(AT) 10 ) encoded in the open reading frame formed SDS-resistant aggregates in WT and rqc2D cells ( Figure S4C ). SDS-resistant aggregates of NS-mtGFP were also observed in rqc1D cells, but to a lesser extent than in ltn1D cells ( Figure 4C ). This is consistent with Rqc1 acting downstream of ubiquitylation by Ltn1. Furthermore, overexpression of NS-mtGFP in ltn1D cells caused growth inhibition ( Figure 4D ) and accumulation of (legend continued on next page) insoluble i-Rip1 ( Figure S4D ) in a manner dependent on Rqc2. In the absence of NS-mtGFP expression, the Rip1 processing defect was only observed upon additional deletion of VMS1 (Figures 2B and 2C) . Vms1D cells did not produce detectable aggregates of the GAL1 inducible NS-mtGFP ( Figure 4E ), consistent with a major contribution of Ltn1 to NS-protein clearance. Surprisingly, vms1Dltn1D cells accumulated lower amounts of high-molecular-weight NS-mtGFP aggregates on SDS-PAGE than ltn1D cells ( Figure 4E ). This observation was inconsistent with the finding that vms1Dltn1D cells contained a similar or greater number of visible NS-mtGFP inclusions compared to ltn1D cells (Figure S4B ). To resolve this apparent contradiction, we analyzed cell lysates by filter retardation assay (Scherzinger et al., 1997) . Indeed, similar amounts of insoluble NS-mtGFP were retained by the filter membrane in vms1Dltn1D cells and ltn1D cells (Figure 4F) . Importantly, when the cell lysates were treated with SDS, aggregates were only detected in vms1Dltn1D cells, but not in ltn1D cells ( Figure 4F ). The cellulose acetate membrane used for filtration had a pore size of 0.2 mm, apparently too large to retain the SDS-resistant NS-mtGFP aggregates of ltn1D cells. In contrast, vms1Dltn1D cells accumulated SDS-resistant aggregates that were large enough to be retained ( Figure 4F ), and this material could not migrate into the high-molecularweight region of the SDS gel ( Figures 4E and S4E) . Thus, the additional deletion of VMS1 enhanced the formation of SDSresistant NS-mtGFP aggregates in ltn1D cells, consistent with the pronounced aggregation of endogenous mitochondrial proteins in the vms1Dltn1D mutant (Figure 3 ). In contrast, VMS1 deletion in ltn1D cells only had a mild effect on the aggregation of cytosolic NS-cGFP ( Figure S4E ), and only small amounts of SDS-resistant aggregates were detectable by filter assay ( Figure S4F ). Moreover, expression of NS-cGFP did not impair the growth of vms1Dltn1D cells, in contrast to NS-mtGFP ( Figure S4G ). Thus, Vms1 protects cells against toxic effects of NS proteins destined to the mitochondria.
Interestingly, the NS-mtGFP immunoprecipitates from vms1Dltn1D cells also contained substantial amounts of the translocase of the outer mitochondrial membrane, Tom40, and of the 60S ribosomal protein Rpl3, whereas only background levels of these proteins were associated with NS-mtGFP in WT and ltn1D cells ( Figure 4E ). Thus, the loss of Vms1 function appears to delay translocation of the ribosome-stalled protein into the mitochondria when ubiquitylation by Ltn1 fails.
Constitutive expression of NS-GFP constructs containing the 3 0 UTR of the CYC1 gene produced higher NS-protein levels. In this case NS-mtGFP aggregates were detectable upon deletion of VMS1 alone ( Figure 4G ). Again these aggregates were Rqc2 dependent ( Figure 4G ). In contrast, NS-cGFP did not aggregate ( Figure 4G ). Similarly, constitutive expression of NS-Shm1, a NS version of the mitochondrial matrix protein serine hydroxymethyl transferase, resulted in Rqc2-dependent aggregation ( Figure S4H ). In contrast, cytosolic NS-Shm1 (lacking the mitochondrial targeting signal) did not aggregate (Figure S4H) . These results suggest that a fraction of NS proteins destined for the mitochondria normally escapes ubiquitylation by Ltn1, resulting in CAT-tail-dependent aggregation in the mitochondria of vms1D cells. Vms1 apparently has a specific role in curtailing this aggregation process, thus preventing toxic effects.
Aggregates of NS Proteins Sequester Mitochondrial Quality-Control Machinery
The aggregation of mitochondrial proteins in vms1Dltn1D cells was dependent on Rqc2 and affected critical quality-control machinery ( Figures 3B-3F ), suggesting that toxicity was caused by CAT-tailed polypeptides that were imported into the mitochondria. To address this possibility, we analyzed the proteins that interacted directly or indirectly with NS-mtGFP by SILAC proteomics in ltn1D and vms1Dltn1D cells (defined as the interactome). WT cells expressing NS-mtGFP served as control. GFP pull-down fractions from cell lysates were subjected to in-solution digest and analyzed by liquid chromatography-tandem MS (LC-MS/MS) (Tables S3A and S4). Identified proteins were considered interactors when they were enriched at least 3-fold over background in at least two of three independent experiments. In addition, SDS-insoluble NS-mtGFP aggregates in ltn1D cells were separated by SDS-PAGE and analyzed by in-gel digest (Tables S3A and S3B) .
A total of 257 proteins were identified as NS-mtGFP interactors in ltn1D cells by in-solution digest ( Figure 5A , left), of which 241 (94%) were mitochondrial, including >26 essential proteins. The SDS-resistant aggregate fraction comprised 63 proteins, all of which were mitochondrial (Table S3B) . Analysis of the NS-mtGFP interactome using ltn1D cells expressing mtGFP as the background identified almost the same set of mitochondrial proteins (95%) (Table S3C), confirming their specific interaction with NS-mtGFP. The interactome included a wide range of metabolic enzymes, respiratory complex proteins and more (C) Deletion of RQC2 in ltn1D cells prevents aggregation. Cell lysates of WT, ltn1D, rqc1D, rqc2D, ltn1Drqc2D , and rqc1Drqc2D cells expressing NS-mtGFP from the GAL1 promoter were subjected to anti-GFP IP and analyzed as in (B) . Asterisk, uncharacterized protein species. (D) Growth of WT, ltn1D, and ltn1Drqc2D cells expressing NS-mtGFP from the GAL1 promoter on SCD (-induction) or SCGal (+ induction) plates at 37 C. 6-fold serial dilutions of cells were spotted on agar plates, and plates were incubated for 3 days (-induction) or 4 days (+ induction). (E) Analysis of NS-mtGFP in ltn1D and vms1Dltn1D cells by IP and IB as in (B) . Co-IP of Tom40 and the 60S ribosomal subunit Rpl3 was detected by IB with specific antibodies. Input fractions were analyzed as controls. schematic of transcripts. Lower: NS-cGFP-3HA and NS-mtGFP-3HA were expressed from the GPD1 promoter in WT, vms1D, and vms1Drqc2D cells grown in SCD medium at 30 C. NS proteins were immunoprecipitated with anti-HA antibody and analyzed as in (B) . Bracket indicates SDS-resistant aggregates. The section of the immunoblot indicated by a dotted rectangle is also shown after longer exposure (arrow). See also Figure S4 .
than 100 factors involved in mitochondrial transcription/ translation and quality control ( Figure 5B , left). These proteins are almost exclusively located in the mitochondrial matrix, confirming that CAT-tail-dependent aggregation occurs after import into the mitochondria. Importantly, among the NS-mtGFP interactors were numerous mitochondrial chaperones and co-chaperones (Hsp60, Hsp78, mtHsp70/Ssc1, Ssq1, Bcs1, Mcx1, Tcm62, Mdj1), and the AAA + protease Pim1, but no cytosolic chaperones ( Figure 5C ; Table S3A ). The association of these proteins with NS-mtGFP presumably reflects a frustrated attempt at preventing aggregation and mediating degradation. Indeed, multiple mitochondrial protein quality-control factors, such as Ssc1, Mdj1, Hsp60, and Pim1, were also detected in the SDS-resistant aggregate fraction ( Figure 5C ; Tables S3A and S3B), suggesting their nonfunctional sequestration.
Analysis of the NS-mtGFP interactome of vms1Dltn1D cells identified essentially the same set of mitochondrial proteins when compared to ltn1D cells (Figures 5A-5C; Table S4 ), although their enrichment on NS-mtGFP was generally greater than in the ltn1D mutant (mean fold enrichment 10.4 and 7.2, respectively) ( Figure 5C ). Strikingly, the NS-mtGFP interactome contained almost all the proteins that were found to be insoluble in the mitochondria of vms1Dltn1D cells not expressing NS-mtGFP ( Figures 3E and 5D ). An additional set of 129 proteins were identified as significant NS-mtGFP interactors in the vms1Dltn1D cells ( Figure 5A ; Table S4 ). These included Tom22 of the outer membrane translocation machinery (Figure 5B, right; Table S4 ) and multiple 60S ribosomal subunits (Table S4) . Tom40, a b-barrel membrane protein, was also significantly enriched (3.5-and 23.6-fold in ltn1D and vms1Dltn1D cells, respectively), albeit with limited peptide recovery by LC-MS/MS (Table  S4) , confirming its co-immunoprecipitation with NS-mtGFP ( Figure 4E ). The identification of TOM components and 60S ribosome subunits in the interactome is consistent with the presence of ribosome-stalled translocation intermediates. Interestingly, we also identified Rqc2 as a prominent NS-mtGFP interactor in the vms1Dltn1D strain ( Figure 5E ; Table S4 ). These findings suggest that in the absence of Vms1, the release of NS-mtGFP from Rqc2-bound 60S ribosomes and import into mitochondria is slowed, extending the time window available for CAT tailing. The NS-mtGFP interactome of vms1Dltn1D cells also contained 48 proteins located in the cytosol or in the cytosol and nucleus (Figure 5A, right; Table S4 ). Notably, these interactors included the chaperone Sis1, which was previously found to be sequestered by cytosolic NS-protein aggregates (Choe et al., 2016) ( Figure 5C ). This indicates that some CAT-tailed NS-mtGFP was retained in the cytosol, possibly due to import sites being clogged.
In summary, CAT-tailed mitochondrial NS proteins aggregate in ltn1D and vms1Dltn1D cells within mitochondria. The aggregates sequester multiple components of the mitochondrial protein synthesis and quality-control machineries. Aggregation is enhanced in the vms1Dltn1D strain, apparently to such an extent that the amounts of endogenously produced NS proteins are sufficient to critically perturb mitochondrial homeostasis. Moreover, overexpression of mitochondrial NS proteins in vms1Dltn1D cells leads to the formation of putative translocation intermediates associated with the outer membrane translocase. An impairment of protein import may thus contribute to the pronounced Rqc2-dependent growth defect of vms1Dltn1D cells under respiratory conditions. Vms1 Counteracts Rqc2-Dependent Aggregate Formation The results described above suggested that Vms1 counteracts the aggregation of CAT-tailed NS proteins. The accumulation of aggregates observed in ltn1D cells may then reflect the limited functional capacity of Vms1. Indeed, overexpression of Myc-tagged Vms1 in ltn1D cells markedly inhibited the Rqc2-dependent aggregation of NS-mtGFP on SDS-PAGE ( Figure 6A , upper) and in the filter trap assay ( Figure S5A ), while the aggregation of cytosolic NS-cGFP decreased to a lesser extent (Figure 6A) . The frequency of fluorescent inclusions in the mitochondria was also markedly reduced ( Figure 6B ). The nonaggregating NS-mtGFP was imported into the mitochondria and distributed over the mitochondrial network ( Figure 6B ). Vms1 overexpression also reduced the amounts of the chaperones Ssq1 and Hsp60 that co-precipitated with NS-mtGFP ( Figure 6A , lower). Moreover, Vms1 suppressed the accumulation of i-Rip1 and the growth defect of ltn1D cells expressing NS-mtGFP or NS-Shm1 ( Figures S5B and S5C ). Thus, Vms1 overexpression phenocopies the effects of RQC2 deletion.
Since overexpression of Vms1 did not change the amount of total NS-mtGFP ( Figure 6A ), Vms1 prevents aggregation not by mediating degradation but rather by interfering with CAT-tail formation itself. CAT-tailed, monomeric NS-mtGFP could not be resolved with the construct containing the 3 0 UTR of the HIS3 gene (see Figure 4A ). However, the NS protein construct containing the 3 0 UTR of the CYC1 gene (see Figure 4G ) allowed us to observe the presence of CAT tails. Note that the resulting NS proteins differ in the length of translated 3 0 UTR sequences, which may affect their resolution on SDS-PAGE. Overexpression of Vms1 in ltn1D cells reduced the amount of CAT-tailed NS-mtGFP, while RQC2 deletion abolished CAT-tail formation ( Figure S5D ).
To investigate how Vms1 interferes with CAT tailing, we next performed sucrose gradient fractionation to see whether Vms1 modulates the association of Rqc2 with 60S ribosomes. Strikingly, Vms1 overexpression caused the displacement of a large fraction of Rqc2 from the ribosomes, without affecting the total cellular amount of Rqc2 ( Figure 6C ). Rqc2 remained ribosomebound in vms1D cells ( Figure 6C ). However, overexpression or deletion of Rqc2 did not affect the level of Vms1 bound to 60S ribosomes ( Figure S5E ). These results demonstrate an inhibitory effect of Vms1 on CAT-tail synthesis by Rqc2. Vms1 may associate with 60S ribosomes at sites partially overlapping with the binding sites for Rqc2.
Vms1 consists of multiple domains whose functions are only partially understood ( Figure 6D ). The C-terminal VIM domain mediates binding to Cdc48 (Heo et al., 2010) . We found that Vms1 lacking the VIM domain, Vms1(DVIM), preserved the ability to bind to 60S ribosomes, but no longer interacted with Cdc48 ( Figure 6E ). Binding of Vms1(DVIM) to Cdc48 was not restored upon deletion of LTN1 ( Figure S6A ). Analysis of the interactors of Vms1(DVIM) by LC-MS/MS identified almost all 60S ribosomal proteins, but not Cdc48 and its adaptors Npl4 and Ufd1 ( Figure 6F ; Table S1 ). Upon overexpression in ltn1D cells, Vms1(DVIM) was as effective as full-length Vms1 in suppressing the aggregation of NS-mtGFP ( Figure S6B ). Moreover, Vms1(DVIM) rescued the processing defect of Rip1 and the growth defect under respiratory conditions in vms1Dltn1D cells (Figures S6C and S6D) .
Together these results demonstrate that Vms1 counteracts the function of Rqc2 in CAT tailing of mitochondrial NS proteins by binding to 60S ribosomes that are associated with Tables S3A and S4 ). (C) Enrichment of mitochondrial and cytosolic protein synthesis and quality-control factors in the NS-mtGFP interactomes of ltn1D and vms1Dltn1D cells. Means enrichment of mitochondrial tRNA ligases and ribosomal proteins is shown. Proteins identified in SDS-resistant NS-mtGFP aggregates in ltn1D cells are indicated by an asterisk (see Tables S3 and S4 ). (SDS-resistant proteins in aggregates of vms1Dltn1D cells could not be determined, because the aggregates were too large to be separated on SDS-PAGE.) (D) Overlap of mitochondrial NS-mtGFP interactors with insoluble mitochondrial proteins in vms1Dltn1D cells (see Figure 3E ; Tables S2A and S4) . (E) Enrichment of Rqc2 in the NS-mtGFP interactomes of ltn1D and vms1Dltn1D cells. Upper: NS-cGFP or NS-mtGFP were expressed from the GAL1 promoter in ltn1D cells without or with overexpression of Vms1-3Myc from the GPD1 promoter (see Figure 1A ). Cell lysates were analyzed by anti-GFP immunoprecipitation (IP) and immunoblotting (IB) as in Figure 4B . Lower: aliquots of anti-GFP IP and input fractions were analyzed by IB against Ssq1, Hsp60, and the Myc-tag of Vms1-3Myc. (B) Vms1 overexpression in ltn1D cells expressing NS-mtGFP reduces visible inclusions. Ltn1D cells expressing NS-mtGFP as in (A) with or without overexpression of Vms1-3Myc were grown at 30 C. Mitochondrial mCherry (mt-mCherry) was co-expressed. The fraction of cells with fluorescent inclusions was quantified (n = 100). Error bars represent SD from three independent experiments. p values from Student's t test. (C) Vms1 overexpression reduces the level of Rqc2 bound to 60S ribosomes. Upper: Vms1-3Myc was expressed in vms1D cells either from its own promoter (designated WT) or overexpressed from the GPD1 promoter (VMS1 OE). Cells expressed Rqc2-3HA from its own promoter. Fractions from sucrose gradient centrifugation were analyzed by IB for Rqc2-3HA and Vms1-3Myc. 60S and 80S ribosomes were detected using anti-Rpl3 antibody. Lower: the same experiment was performed with WT and vms1D cells expressing Rqc2-3HA. T, top and B, bottom of the gradient.
(legend continued on next page)
mitochondria. This function of Vms1 is independent of its interaction with Cdc48.
DISCUSSION
We have shown that Vms1 functions in a cytosolic protein quality-control pathway that prevents the loss of mitochondrial function and preserves cell viability under respiratory conditions. Surprisingly, normal unstressed yeast cells continually produce faulty mitochondrial proteins that stall on ribosomes during translation and can cause pronounced toxicity upon import into the organelles. CAT tailing of these stalled polypeptides by Rqc2 results in widespread mitochondrial protein aggregation and is responsible for the toxic effects. Vms1 associates with 60S ribosomes and acts synergistically with the E3 ligase Ltn1 in a rescue pathway for ribosome-stalled polypeptides (mitoRQC) to prevent toxic effects of CAT-tailed proteins in the mitochondria.
RQC of Mitochondrial versus Cytosolic Proteins
Cytosolic proteins that stall on ribosomes due to mRNA defects are recognized by the RQC machinery and efficiently targeted for proteasomal degradation (Brandman and Hegde, 2016 ) ( Figure 7A ). In contrast, stalled mitochondrial proteins synthesized in the cytosol and exposing N-terminal targeting sequences may escape the RQC by co-translationally engaging the mitochondrial translocation machinery, undergoing partial import into the mitochondria before the RQC response is triggered ( Figure 7B ). As a result, stalled mitochondrial polypeptides may translocate across the outer and inner mitochondrial membranes up to a point where the 80S ribosome (60S after splitting) halts further translocation (Izawa et al., 2012) . This would generate a topology in which the 60S ribosome is in close proximity to the TOM complex, the protein translocase of the outer mitochondrial membrane (Figure 7B) . As shown previously, tightly folded protein domains fused to the C terminus of mitochondrially targeted proteins are held in contact to the TOM complex on the mitochondrial surface (Ungermann et al., 1994) by the ''pulling'' force of the mitochondrial import motor (Neupert and Brunner, 2002; Wiedemann and Pfanner, 2017) . 60S ribosomes carrying nascent chains likely experience the same close attachment to the outer membrane, restricting access of RQC machinery to the translocating chain. Ltn1 may ubiquitylate stalled chains before they undergo import, and our results suggest that this is the case for a substantial fraction of stalled polypeptides destined to mitochondria. Nascent chains may also expose lysine residues to the cytosol during translocation, particularly lysines close to their C terminus, which would be accessible to ribosome-bound Ltn1 (Kostova et al., 2017) . Such partially translocated and ubiquitylated chains may then be extracted from the translocon by Cdc48 and degraded by the proteasome ( Figure 7B ). However, ubiquitylation by Ltn1 will fail when C-terminal lysines are either absent or the 60S ribosome is too close to the outer mitochondrial membrane. As a result, stalling will be prolonged and a CAT-tail sequence will be attached to the nascent chain by Rqc2. Upon import into the mitochondria, these CAT-tailed polypeptides aggregate and sequester chaperones and proteases ( Figure 7C ), eventually leading to respiratory deficiency and a breakdown of mitochondrial function. Vms1 functions to circumvent this problem and thus can be defined as a RQC component specifically adapted to curtailing the detrimental effects of stalled polypeptides that undergo membrane translocation. While Vms1 function is adequate for the limited amount of stalled chains that escape ubiquitylation by Ltn1, it becomes acutely essential when Ltn1 is defective, amplifying the amount of CAT-tailed, aggregation-prone proteins entering the mitochondria. The accumulation of defective respiratory complexes under these conditions results in mitochondrial dysfunction and generates high levels of oxygen radicals (Wallace, 2005) , with the resulting oxidative damage possibly enhancing the production of aberrant proteins ( Figure 7C ).
Mechanism of Vms1 in Restricting CAT Tailing
Our results assign a key role to Vms1 in protecting mitochondria against the toxic effects of CAT-tailed proteins. Vms1 restricts the accumulation of these aggregation-prone proteins not by facilitating their degradation, but rather by preventing CAT-tail formation itself. This activity is independent of the functional interaction of Vms1 with Cdc48. By restricting CAT tailing, Vms1 facilitates passage of less aggregation-prone proteins into the mitochondrial matrix that can then be dealt with by the intra-mitochondrial quality-control system ( Figure 7B ).
We found that overexpression of Vms1 caused the displacement of Rqc2 from 60S ribosomes, providing a mechanism for how Vms1 impedes CAT tailing. Vms1 may directly compete with Rqc2 for 60S binding, consistent with Vms1 and Rqc2 being of similar abundance (Wang et al., 2015) . Vms1 may also prevent the re-association of 60S and 40S ribosomes, thereby facilitating access of peptidyl-tRNA hydrolases and accelerating the release of stalled proteins for import into the mitochondria. This would reduce the time available for CAT tailing. Conversely, our results indicated that in the absence of Vms1, the residence time of NS protein on Rqc2-bound 60S ribosomes is prolonged and stalled chains accumulate in association with the TOM machinery. As a result, CAT tailing is more extensive and aggregation of NS protein upon import is enhanced ( Figure 7C ). Table S1 ). See also Figures S5 and S6 .
Although Vms1 may also reduce CAT tailing for proteins remaining in the cytosol, our data argue for a preferential role of Vms1 in RQC of proteins destined to the mitochondria. Specificity for 60S ribosomes associated with mitochondria may involve an affinity of Vms1 for proteins of the outer mitochondrial membrane or for the lipid phase. An additional role of Vms1 in RQC of secretory proteins would be consistent with the partial localization of Vms1 to the ER membrane (Tran et al., 2011) and the accumulation of 60S-bound chains at the translocon (von der Malsburg et al., 2015) . Indeed, our Vms1 pull-down experiments identified several components of the ER translocation machinery, including Sec61, Sec62, Sec63, Sec66, and Sec72 (Table S1 ).
Evolutionary Considerations
As Rqc2 has been highly conserved from yeast to human, it is tempting to speculate that the existence of Rqc2 presented a critical problem during the endosymbiotic evolution of mitochondria. As genes of the endosymbiont were exported to the nucleus of the host, the synthesis of the respective proteins, now taking place on cytosolic ribosomes, would likely have led to translational stalling at a certain frequency, resulting in the production and import of CAT-tailed proteins. The RQC2 gene comprising the conserved aminoacyl tRNA binding site is already present in archaea ( Figure S7 ) and thus would have been present in the endosymbiotic host. In contrast, the VMS1 gene is absent from archaeal genomes and may have evolved during endosymbiosis to cope with the problem of CAT tailing.
Taking into account that Vms1 and all other components of the RQC are conserved in mammalian cells, the protein quality-control pathway described here is probably of general biological significance. Defects in this pathway, or its agedependent decline, may be the cause of human diseases associated with mitochondrial dysfunction and neurodegeneration (van Haaften-Visser et al., 2017) .
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EXPERIMENTAL MODEL AND SUBJECT DETAILS
Strains used in this study were S. cerevisiae BY4741 and BY4742. The genotypes of the strains and their mutant derivatives are listed in KEY RESOURCES TABLE. Cells were grown in YP or synthetic complete (SC) medium at 23 C, 30 C or 37 C (Izawa and Unger, 2017) . The respective media contained either 2% glucose (YPD, SCD), 3% galactose (YPGal, SCGal), 3% glycerol (YPG), 2% raffinose (SCRaf) or 1% raffinose/3% galactose (SCRaf/Gal). The amount of yeast cells used in the various experiments was defined as OD 600 units (1 OD 600 cells corresponds to the amount of yeast cells present in 1 mL of a culture with an OD 600 of 1). 
METHOD DETAILS
Yeast strains Chromosomal manipulations of yeast strains (deletions, C-terminal 3xHA-and 3xMyc tagging) were performed by homologous recombination using PCR amplified DNA cassettes (Knop et al., 1999) . PCR was performed using Phusion High-Fidelity DNA Polymerase (NEB) or Q5 High-Fidelity DNA Polymerase (NEB). To construct the DNA cassettes for gene deletion, the DNA sequence containing a selection marker (HIS3MX4, kanMX4, hphNT1 or K. lactis LEU2) was flanked at the 5 0 -end by a 45 bp sequence identical to the 5 0 -end of the region to be deleted and at the 3 0 -end by a 45 bp sequence identical to the 3 0 -end of the region to be deleted. To construct the DNA cassettes for 3xHA and 3xMyc tagging, the DNA sequence encoding 3xHA or 3xMyc with ADH1 terminator and containing a HIS3MX4 selection marker was flanked at the 5 0 -end by 45 bp sequence identical to the 45 bp upstream of the stop codon of the target gene and at the 3 0 -end by 45 bp sequence identical to the 45 bp downstream of the stop codon of the target gene.
Plasmid construction
Plasmids used in this study are listed in the KEY RESOURCES TABLE. Primers used for plasmid construction are listed in Table S5 . DNA cloning was performed either by DNA ligation using T4 DNA ligase (NEB) or by the Gibson Assembly method (Gibson et al., 2009) . PCR was performed using Phusion High-Fidelity DNA Polymerase (NEB) or Q5 High-Fidelity DNA Polymerase (NEB).
A DNA fragment encoding Vms1-3xMYC was amplified from yeast genomic DNA of strain IZWN-Y14 (see KEY RESOURCES TABLE) by PCR using primers IZWN-oligo1 and IZWN-oligo2 and cloned into the SpeI and XhoI sites of p416GPD and p415GPD (Mumberg et al., 1995) to generate pIZWN1 and pIZWN2, respectively. A DNA fragment encoding Vms1-3xHA was amplified from yeast genomic DNA of strain IZWN-Y16 (see KEY RESOURCES TABLE) by PCR using primers IZWN-oligo1 and IZWN-oligo2 and cloned into the SpeI and XhoI sites of p416GPD to generate pIZWN3. A DNA fragment encoding Vms1 was amplified from yeast genomic DNA of BY4742 by PCR using primers IZWN-oligo3 and IZWN-oligo4 and cloned into the SpeI and XhoI sites of p415GPD to generate pIZWN4. A DNA fragment for expression of Vms1-3xMYC from its own promoter was amplified from yeast genomic DNA of strain IZWN-Y14 by PCR using primers IZWN-oligo5 and IZWN-oligo6 and cloned into the SpeI and XhoI sites of pRS316 and pRS415 (Sikorski and Hieter, 1989) to generate pIZWN5 and pIZWN6, respectively. pIZWN7, pIZWN8 and pIZWN9, for expression of the Vms1 (DVIM)-3xMYC mutant, were constructed by site-directed mutagenesis by PCR using primers IZWN-oligo 7 and IZWN-oligo 8. For expression of NS-mtGFP and mtGFP from the GAL1 promoter, a DNA fragment containing the GAL1 promoter and the sequence encoding the N-terminal 1-69 residues of subunit 9 of mitochondrial F1Fo-ATP synthase was amplified from pYES-mtGFP (Westermann and Neupert, 2000) by PCR using primers 5GAL-Sac1 and 3Su9-Xba1, and cloned into the SacI and XbaI sites of p416GAL-NS-GFP and p416GAL-GFP (Choe et al., 2016) to generate p416GAL1-NS-mtGFP and p416GAL1-mtGFP, respectively. A DNA fragment containing the GAL1 promoter and the NS-cGFP or NS-mtGFP sequence was isolated from p416GAL1-NS-GFP or p416GAL1-NS-mtGFP, respectively, by digestion with SacI and EcoRI and sub-cloned into the SacI and EcoRI sites of pRS426 to generate p426GAL1-NS-cGFP or p426GAL1-NS-mtGFP, respectively. The plasmids for expression of NS-proteins from the GPD1 promoter were constructed as follows. A DNA fragment encoding a 2xMYC tag was amplified from pYM4 (Janke et al., 2004) by PCR using primers IZWN-oligo9 and IZWN-oligo10 and cloned into the SpeI and EcoRI sites of pIZN1 (Izawa et al., 2012) to generate p416GPD-NS-2xMYC. A DNA fragment encoding 3xHA tags was amplified from pYM1 (Janke et al., 2004) by PCR using primers IZWN-oligo11 and IZWN-oligo12 and cloned into the SpeI and EcoRI sites of pIZN1 to generate p416GPD-NS-3xHA. DNA fragments encoding NS-cGFP and NS-mtGFP were amplified from pVT100U-mtGFP (Westermann and Neupert, 2000) by PCR using primers IZWN-oligo13 and IZWN-oligo14 (for NS-cGFP) and IZWN-oligo15 and IZWN-oligo14 (for NS-mtGFP), and cloned into the SpeI site of p416GPD-NS-3xHA to generate pIZWN10 and pIZWN11, respectively. The NS-mtGFP DNA fragment was cloned into the SpeI site of p416GPD-NS-3xMYC to generate pIZWN12. DNA fragments encoding Shm1 without the stop codon and its variant lacking the N-terminal mitochondrial targeting signal (residues 2-19) (NS-Shm1 and NS-DMTS-Shm1, respectively) were amplified from yeast genomic DNA of strain BY4742 by PCR using primers IZWN-oligo16 and IZWN-oligo17 (for NS-Shm1) and IZWN-oligo18 and IZWN-oligo19 (for NS-DMTS-Shm1), and cloned into the SpeI site of p416GPD-NS-3xMYC to generate pIZWN13 and pIZWN14, respectively. A DNA fragment encoding mtGFP fused at the C terminus with 10 Ala-Thr repeats (mtGFP-(AT) 10 ) or 10 Gly-Ser repeats (mtGFP-(GS) 10 ), followed by a stop codon, was amplified from p416GAL1-NS-mtGFP by PCR using primers IZWN-oligo15 and 3GFP-(AT) 10 EcoRI (for mtGFP-(AT) 10 ) or IZWN-oligo15 and 3GFP-(GS) 10 EcoRI (for mtGFP-(GS) 10 ) and cloned into p416GAL1 to generate p416GAL1-mtGFP-(AT) 10 or p416GAL1-mtGFP-(GS) 10 , respectively. A DNA fragment encoding mCherry fused at the N terminus with the N-terminal 1-69 residues of subunit 9 of mitochondrial F1Fo-ATP synthase, expressed from the TEF1 promoter and terminator, was amplified from the plasmid KOB152 (a gift from Koji Okamoto) by PCR using primers IZWN-oligo20 and IZWN-oligo21 and cloned into the SacI and XhoI sites of pRS313 and pRS415 (Sikorski and Hieter, 1989) to generate pIZWN15 and pIZWN16, respectively. A DNA fragment encoding Rip1 was amplified from yeast genomic DNA of BY4742 by PCR using primers IZWN-oligo22 and IZWN-oligo23 and cloned into the SpeI and XhoI sites of p416GPD to generate pIZWN17.
Preparation of total cell extracts for immunoblot analysis 2 OD 600 cells grown in liquid medium were harvested by centrifugation at 6,000 x g for 2 min. Cells were resuspended in 1 mL of ice-cold water to which 150 ml of 2 M sodium hydroxide solution containing 7% b-mercaptoethanol was added, followed by vortexing and incubation for 10 min on ice. 200 ml of 50% trichloroacetic acid (TCA) was then added, followed by mixing and incubation for 10 min on ice. The sample was centrifuged at 17,000 x g for 10 min and the supernatant was discarded. The pellet was washed once with 700 ml of ice-cold aceton and centrifuged again at 17,000 x g for 5 min. The pellet was air-dried and resuspended in 100 ml of HU buffer (8 M urea, 5% SDS, 200 mM Tris-HCl pH 6.8, 1 mM EDTA, 0.01% bromophenol blue, 2% b-mercaptoethanol).
SDS-PAGE
Protein samples were separated by electrophoresis on SDS polyacrylamide gels consisting of running gels (380 mM Tris-HCl pH 8.8, 0.1% SDS, 8%-15% of acrylamide, 0.21 À0.40% bis-acrylamide) and stacking gels (60 mM Tris-HCl pH 6.8, 0.1% SDS, 5% acrylamide, 0.13% bis-acrylamide). Proteins were separated with SDS-PAGE running buffer (25 mM Tris, 250 mM glycine, 0.1% SDS) at 40 mA. For analyses of NS-proteins and engineered CAT-tailed proteins (except for Figures S4H and S5D ), proteins were separated on NuPAGE 4%-12% Bis-Tris SDS gels (Invitrogen) using NuPAGE MOPS SDS running buffer (Invitrogen) or NuPAGE MES SDS running buffer (Invitrogen) at 200 V.
Blue-Native PAGE For Blue-Native electrophoresis, proteins of isolated mitochondrial fractions (2 mg protein for immunoblotting with anti-F1b and 20 mg for immunoblotting with anti-Cyt1 antibodies) were incubated in 100 ml of Blue-Native PAGE buffer (50 mM NaCl, 50 mM imidazole, 1 mM EDTA, 3% digitonin, pH 7.0) for 10 min at 4 C (Wittig et al., 2006) and mixed with 13 ml of Native PAGE 5% G-250 Sample Additive (Invitrogen) and 18 ml of 30% glycerol. The samples were separated by electrophoresis on NativePAGE 3%-12% Bis-Tris gels (Invitrogen) with NativePAGE Anode Buffer and NativePAGE Dark Blue Cathode Buffer (Invitrogen) for 35 min at 150 V and then with NativePAGE Anode Buffer and NativePAGE Light Blue Cathode Buffer (Invitrogen) for 140 min at 250 V.
Immunoblotting
Proteins were transferred from polyacrylamide gels to nitrocellulose (GE healthcare) or PVDF (Carl Roth) membranes in blotting buffer (25 mM Tris, 192 mM glycine, 20% methanol) at 380 mA ( Figures 2B-2D , 3B, 3C, 4G, 6C, S1, S2C, S3, S4A, S4C, S4D, S4H, S5B, S5D, S5E, S6A, and S6C) or at a constant voltage of 55 V ( Figures 4B, 4C , 4E, 4F, 6A, S4E, S4F, S5A, and S5B). Membranes were washed in TBST buffer (10 mM Tris-HCl pH 7.5, 150 mM NaCl, 0.05% Tween-20) and blocked with 2% skim milk in TBST buffer for 1 hr at room-temperature. Membranes were incubated with primary antibodies in TBST buffer overnight at 4 C and washed 5 times with TBST (5 min for each wash). Membranes were then incubated with secondary antibody for 1 hr at room-temperature and again washed 5 times with TBST. IRDye conjugated (LI-COR) or horseradish peroxidase (HRP)-conjugated (Bio-Rad, Dako or Sigma-Aldrich) secondary antibodies were used. ECL Plus Western Blotting Substrate (Thermo Scientific) was used as substrate of HRP. The Odyssey imaging system (LI-COR), ImageQuant LAS 4000 mini (GE Healthcare) or X-Ray film Super RX (Fuji Film) were used for signal detection. Images were analyzed using Image Studio Lite (LI-COR) or AIDA software (Raytest).
Immunoblot analyses in Figures 2, 3C , 4, 6, S1, S4A, S4C, S4E, S4F, S5A, S5D, S5E, and S6B were conducted in at least two independent experiments. The immunoblots in Figure S5B were conducted four times (for NS-mtGFP) and three times (for NS-Shm1) and the levels of i-Rip1 related to total Rip1 (i-Rip1 + m-Rip1) were quantified using image Studio Lite (LI-COR). The immunoblots in Figures 3B and S3 were conducted once and the results confirmed by proteomic analysis (Table S2) . Immunoblots in Figures S2C,  S4D , S4H, S6A, and S6C were conducted once.
Extraction of total RNA Total RNA was extracted as follows. 10 OD 600 of cells were resuspended in 400 ml of TES buffer (10 mM Tris-HCl pH 7.4, 10 mM EDTA, 0.5% SDS), mixed with 400 ml of acid phenol and incubated at 65 C with shaking for 45 min. The reactions were incubated on ice for 5 min, centrifuged at 17,000 x g for 10 min and the water phases were collected. The samples were then mixed with 400 ml of chloroform, vortexed for 1 min, centrifuged at 17,000 x g for 5 min and collected. This procedure was repeated twice. 280 ml of supernatant was mixed with 28 ml of 3M sodium acetate (pH 5.0) and 770 ml of ice-cold ethanol followed by incubation at À20 C for 20 min. Total RNA was precipitated by centrifugation at 17,000 x g for 10 min at 4 C. After removal of the supernatant, the pellet was washed once with 1 mL of 70% ethanol and centrifuged at 17,000 x g for 5 min at 4 C. After removal of the supernatant, the pellet was resuspended in 50 ml of water.
Northern blotting 20 ml of total RNA (concentration adjusted to 0.5 mg/ml) was mixed with 40 ml of loading buffer (50% formamid, 6.1% formaldehyde, 10% glycerol, 0.05% bromophenol blue in 1 x MOPS buffer [20 mM MOPS-NaOH pH 7.0, 5 mM sodium acetate, 2 mM EDTA]) and denatured at 65 C for 10 min. 1-3 mg of total RNA was separated by electrophoresis on agarose gels (1.8% agarose and 2% formaldehyde in 1 x MOPS buffer) and subjected to capillary transfer with 20 x SSC (300 mM sodium citrate pH 7.0, 3 M sodium chloride) to Hybond-N nylon membranes (GE Healthcare). RNA was fixed on the membrane by cross linking with UV light at 120 mJ using UV Stratalinker (Stratagene). The membrane was then rinsed with water and air-dried. The digoxigenin(DIG)-labeled probes were synthesized using the PCR DIG Probe Synthesis Kit (Roche). The primers IZWN-oligo22 and IZWN-oligo23, and IZWN-oligo24 and IZWN-oligo25, were used to synthesize the probes for RIP1 mRNA and SCR1 RNA, respectively. The membrane was pre-incubated with pre-warmed DIG Easy Hyb (Roche) for 30 min at 50 C. DIG-labeled RNA probe was denatured by boiling for 5 min and rapidly cooling on ice. The membrane was then incubated with pre-warmed DIG Easy Hyb containing denatured DIG-labeled RNA probe overnight at 50 C with gentle agitation. The membrane was washed twice with 2 x SSC containing 0.1% SDS at room-temperature for 5 min and twice with 0.2 x SSC containing 0.1% SDS at 50 C for 15 min. The membrane was then washed briefly with washing buffer (100 mM maleic acid-NaOH pH 7.5, 150 mM sodium chloride, 0.3% Tween-20) and incubated with blocking solution (1 x blocking solution [Roche], 100 mM maleic acid, 150 mM sodium chloride) for 30 min at room-temperature. The membrane was then incubated with blocking solution containing anti-digoxigenin-AP (Roche) for 30 min at room-temperature, washed twice with washing buffer for 15 min and equilibrated with detection buffer (100 mM Tris-HCl pH 9.5, 100 mM sodium chloride). CDP-Star (Roche) was used for signal detection using X-Ray film Super RX (Fuji Film).
Northern blot analyses in Figure S2B were conducted twice (YPD) and once (YPGal and YPG).
Isolation of mitochondria
Cells were grown to log phase in YPD medium at 30 C or YPGal medium at 37 C. Mitochondria were isolated by differential centrifugation (Izawa and Unger, 2017) . 500 OD 600 cells were harvested by centrifugation at 2,000 x g for 5 min, washed with 30 mL of water and incubated with 10 mL of alkaline solution (100 mM Tris pH not adjusted, 10 mM DTT) for 10 min at 30 C. Cells were harvested by centrifugation at 2,000 x g for 5 min, washed once with 10 mL of spheroplast buffer (20 mM Tris-HCl pH 7.4, 1 mM EDTA, 1.2 M sorbitol) and incubated in 10 mL of spheroplast buffer containing 1 mg/ml zymolyase 20T for 20 min at 30 C. The resulting spheroplasts were harvested by centrifugation at 2,000 x g for 5 min at 4 C and washed briefly with 30 mL of ice-cold homogenization buffer (20 mM MOPS-KOH pH 7.2, 1 mM EDTA, 0.6 M sorbitol, 0.2% (w/v) BSA, 1 mM phenylmethylsulfonyl fluoride (PMSF)). This washing step was repeated twice. The spheroplasts were homogenized with 10 mL of homogenization buffer by repeated pipetting (approximately 40 times) using a P5000 tip with 1 cm cut off. The homogenates were centrifuged at 2,000 x g for 5 min and the supernatants were collected. The pellet fractions were homogenized again with 10 mL of homogenization buffer by repeated pipetting (approximately 30 times) as above. The homogenates were centrifuged at 2,000 x g for 5 min and the supernatants were collected again. The combined supernatants were centrifuged at 2,000 x g for 5 min to remove the remaining cell debris. The supernatants were centrifuged at 12,000 x g for 10 min to collect the pellet fractions containing mitochondria. The pellet fractions were resuspended in 500 ml of SEM buffer (20 mM MOPS-KOH pH 7.2, 1 mM EDTA, 0.6 M sorbitol), protein concentration determined using Bio-rad Protein Assay Dye Reagent (Bio-Rad) and Bio-rad Protein Assay Standard I (Bio-Rad), and divided into 50 ml aliquots with a protein concentration of 5-10 mg/ml. The aliquots were frozen in liquid nitrogen and stored at À80 C. The aliquots were dissolved in SDS buffer (50 mM Tris-HCl pH 6.8, 2% SDS, 1 mM EDTA, 10% glycerol, 0.01% bromophenol blue) and analyzed by SDS-PAGE and immunoblotting.
Immunoprecipitation of Vms1
Vms1D cells expressing VMS1-3xHA (Control), VMS1-3xMYC or VMS1(DVIM)-3xMYC from the GPD1 promoter were grown to log phase in SCD medium at 30 C. 50 OD 600 cells were harvested and resuspended in 500 ml of IP buffer (50 mM Tris-HCl pH 7.4, 20 mM KCl, 10 mM MgCl 2 , 1 mM PMSF, Protease Inhibitor Cocktail [Roche]). Cells were lysed by agitation with glass beads followed by addition of 500 ml of IP buffer containing 1% Triton X-100. After incubation for 10 min on ice, insoluble material was removed by centrifugation at 21,000 x g for 10 min at 4 C. The resulting lysates were incubated with anti-Myc monoclonal antibody (Max Planck Institute of Biochemistry) and 12.5 ml of Protein A Sepharose CL-4B (GE healthcare) for 2 hr at 4 C and centrifuged at 1,000 x g for 30 s. After removal of supernatant, the immunoprecipitates were washed with 700 ml of IP buffer containing 0.5% Triton X-100 and centrifuged at 1,000 x g for 20 s. This washing step was repeated four times. The immunoprecipitates were then washed once with 700 ml of IP buffer and centrifuged at 1,000 x g for 20 s. After removal of supernatants, proteins co-precipitated with protein A Sepharose were eluted with 50 ml of SDS buffer and analyzed by SDS-PAGE and Coomassie Brilliant Blue (CBB) staining.
The immunoprecipitation experiments in Figures 1A and 6E were independently conducted at least 3-times.
Aggregation assay 50 OD 600 cells grown in YPGal medium at 37 C were harvested and resuspended in 500 ml of IP buffer. Cells were lysed as described in ''Immunoprecipitation of Vms1.'' After incubation for 10 min on ice, insoluble material was removed by centrifugation at 845 x g for 5 min at 4 C. The resulting lysates (total) were fractionated into soluble (supernatant) and insoluble (pellet) fractions by centrifugation at 20,000 x g for 15 min at 4 C. Proteins in 50 ml of total and soluble fractions were precipitated by adding 450 ml of ice-cold water and 50 ml of 72% TCA and incubating for 10 min on ice. The precipitates were collected by centrifugation at 17,000 x g for 10 min at 4 C and the pellets washed once with 700 ml of ice-cold acetone. After removal of acetone, the pellets were air-dried. The resulting total, soluble and insoluble fractions were solubilized in 100 ml of HU buffer. Proteins were analyzed by SDS-PAGE and immunoblotting. respectively (Cambridge Isotope Laboratories). Ltn1D, vms1Dltn1D and vms1Dltn1Drqc2D cells were grown in SCGal medium containing either (L), (H) or (M) lysine at 37 C. 60 OD 600 cells were lysed as described above. Aliquots containing 1 mg of proteins from (L), (H) and (M) lysates were mixed (total 3 mg). Total fraction containing 2.6 mg of proteins was then fractionated into soluble (supernatant) and insoluble (pellet) proteins at 20,000 x g for 15 min at 4 C. A volume of supernatant corresponding to 400 mg of total fraction was collected for TCA precipitation. 400 mg of total fraction was also TCA-precipitated. For TCA-precipitation, total and soluble fractions were brought to a volume of 1 mL by adding ice-cold water, followed by addition of 150 ml of 50% TCA, mixing and incubation for 10 min on ice. The precipitates were collected by centrifugation at 17,000 x g for 10 min at 4 C and pellets washed once with 700 ml of ice-cold acetone. After removal of acetone, the pellets were air-dried. The resulting total, soluble and insoluble fractions were solubilized in 100 ml of HU buffer without bromophenol blue.
SILAC labeling for analysis of aggregated proteins
Immuno-purification of NS-proteins
Immuno-purification of NS-cGFP and NS-mtGFP expressed from the GAL1 promoter was performed as follows. Yeast cells grown at 30 C in SCRaf medium were shifted to SCRaf/Gal medium to induce NS-proteins for 20 hr. Cells were harvested and lysates were prepared in lysis buffer (25 mM Tris-HCl pH 7.5, 50 mM KCl, 10 mM MgCl 2 , 1 mM EDTA, 5% glycerol, 0.5% Triton X-100, Protease Inhibitor Cocktail [Roche]) using a FastPrep-24 homogenizer with CoolPrep adaptor (MP Biomedical). Lysates were cleared by centrifugation at 1,000 x g for 10 min at 4 C. For detection of ubiquitylated proteins, cells were lysed in denaturing buffer (10 mM Tris-HCl pH 8.0, 100 mM NaH 2 PO 4 , 6 M guanidinium chloride), and after removal of cell debris at 20,000 x g for 10 min, the lysates were applied to a desalting column (PD-10) for buffer exchange to lysis buffer. Aliquots of supernatant fractions equivalent to 2 mg of protein were incubated with 50 ml of anti-GFP MicroBeads suspension (Miltenyi Biotech) for 2 hr at 4 C. After four washes with 600 ml of lysis buffer, bound proteins were eluted with 70 ml of HU buffer. 1 mL of sample corresponding to 500 mg input fraction was mixed with 150 ml of 50% TCA and incubated for 10 min on ice. The precipitates were centrifuged at 20,000 x g for 20 min at 4 C and the pellets were washed once with 1 mL of ice-cold acetone. After removal of acetone, the pellets were air-dried and resuspended in 100 ml of HU buffer.
Immuno-purification of constitutively expressed NS-proteins from the GPD1 promoter was performed as follows. 150 OD 600 cells were grown to log phase, harvested and lyzed as described in ''Immunoprecipitation of Vms1.'' The lysates were cleared by centrifugation at 845 x g for 5 min at 4 C, incubated with 10 ml of anti-HA affinity matrix (Roche) for 2 hr at 4 C and centrifuged at 1,000 x g for 30 s. After removal of supernatant, the immunoprecipitates were washed with 500 ml of IP buffer containing 0.5% Triton X-100 and centrifuged at 1,000 x g for 20 s. This washing step was repeated four times. The immunoprecipitates were then washed once with 500 ml of IP buffer and centrifuged at 1,000 x g for 20 s. After removal of supernatants, proteins co-precipitated with anti-HA affinity matrix were eluted with 35 ml of SDS buffer. The samples were analyzed by NuPAGE 4%-12% Bis-Tris Gel (Invitrogen) electrophoresis and immunoblotting.
SILAC labeling for analysis of the NS-mtGFP interactome SILAC labeling and proteomic analysis were carried out essentially as described (Choe et al., 2016) . WT, ltn1D and vms1Dltn1D cells were grown in SCRaf medium containing either (L), (H) or (M) lysine at 30 C and were shifted to SCRaf/Gal medium again containing (L), (H) or (M) lysine at 30 C to induce NS-protein expression for 20 hr. Preparation of cell lysates and immuno-purification of NS-mtGFP or mtGFP were performed as described in ''Immuno-purification of NS-proteins.'' In Tables S3A and S4 , aliquots of (L), (H) and (M) labeled lysates were mixed, then subjected to immuno-purification with anti-GFP MicroBeads. In Tables S3B and  S3C , aliquots of (L) and (H) labaled lysates were subjected to immuno-purification followed by mixing. Immunoprecipitates were eluted with 70 ml of elution buffer (5% SDS, 200 mM Tris-HCl pH 6.8, 1 mM EDTA, 2% b-mercaptoethanol) for in-solution digestion or HU buffer for in-gel digestion.
In-gel digestion For the identification of Vms1 interactors in Table S1 , the immunoprecipitated proteins were separated on 15% SDS polyacrylamide gels and stained with CBB. The entire lane was sliced into gel pieces (approximately 1 mm 3 in size). The gel pieces were destained twice with 250 ml of 25 mM ammonium bicarbonate (ABC)/50% ethanol solution and dehydrated with ethanol. Dehydrated gel pieces were reduced with 20 mM DTT in 50 mM ABC for 60 min at 56 C and alkylated with 40 mM chloroacetamide in 50 mM ABC for 30 min at room temperature. After washing with 50 mM ABC and dehydration with ethanol, the gel pieces were re-hydrated with 100 ml of digestion solution (12.5 ng/ml trypsin [Promega] in 50 mM ABC) for overnight digestion at 37 C. The digested peptides were extracted from gel pieces once with 500 ml of 30% acetonitrile (ACN)/3% trifluoroacetic acid (TFA) and once with 300 ml of ACN. The eluate was concentrated to approximately 100 ml in a vacuum centrifuge concentrator and desalted with C18 StageTips. C18 StageTips were made by stacking three punch-outs of C18 Empore Disks (Sigma-Aldrich) into a 200 ml micropipette tip (Rappsilber et al., 2007) . The C18 StageTips were washed with 100 ml of ACN and centrifuged at 1,200 rpm. This washing step was repeated twice. The C18 StageTips were then washed with 100 ml of 0.1% TFA and centrifuged at 1,200 rpm. This washing step was repeated three times. The samples were then loaded onto the C18 StageTips and centrifuged at 1,000 rpm. The flow-through was loaded onto the same StageTip again and centrifuged at 1,000 rpm. The StageTips were washed with 100 ml of 0.1% TFA and centrifuged at 1,200 rpm. This washing step was repeated twice. Peptides were eluted from the StageTips with 60 ml of 0.1% formic acid/80% ACN by centrifugation at 1,200 rpm and the volume was reduced to 6 ml using a vacuum centrifuge concentrator.
For the identification of NS-mtGFP interactors sequestered into SDS-resistant aggregates (Table S3B) , the samples were separated on NuPAGE 4%-12% Bis-Tris gels (Invitrogen) and stained with CBB. After destaining, the gel pieces containing proteins migrating above 170 kDa were sliced into cubes (approximately 1 mm 3 in size) using a razor blade. After washing with 50 mM ABC, gel pieces were dehydrated with ACN. Dehydrated gel pieces were reduced with 10 mM DTT in 50 mM ABC for 45 min at 56 C and alkylated with 55 mM iodoacetamide in 50 mM ABC for 30 min at room temperature in the dark. After washing with 50 mM ABC and dehydration with ACN, gel pieces were rehydrated in 150 ml of 50 mM ABC solution containing 15 ng/ml Lysyl endopeptidase (Wako) and incubated overnight at 37 C. Peptides were extracted from gel pieces once with 750 ml of 5% formic acid/30% ACN and once with 300 ml of ACN. After drying in a vacuum centrifuge concentrator, the samples were dissolved in 100 ml of 0.1% TFA and were desalted with C18 StageTips as described above. C18 StageTips were made by stacking two punch-outs of C18 Empore Disks (Sigma-Aldrich) into a 200 ml micropipette tip. After being desalted, peptides were eluted from the StageTips twice with 10 ml of 1% formic acid/70% ACN by centrifugation at 1,200 rpm. The samples were dried using the vacuum centrifuge concentrator and resuspended in 10 ml of 5% formic acid.
The experiments in Figures 1B, 1C , and 6F were independently conducted twice, and the experiments in Figure 5C three times.
In-solution digestion
For the identification of insoluble proteins in Table S2 and the identification of NS-mtGFP interactors in Tables S3A, S3C , and S4, the Filter Aided Sample Prep (FASP) method was used to generate peptides for LC-MS/MS analysis (Wi sniewski et al., 2009 ). The total, soluble and insoluble fractions described in ''SILAC labeling for analysis of aggregated proteins'' were analyzed for Table S2 . The immunoprecipitates described in ''SILAC labeling for analysis of the NS-mtGFP interactome'' were analyzed for Tables S3A, S3C , and S4. The samples were mixed with 200 ml of UA buffer (8.0 M urea in 100 mM Tris-HCl pH 8.5) in Amicon Ultra centrifugal ultrafiltration units (EMD Millipore) with a nominal molecular weight cut-off of 10,000 Da, and centrifuged at 14,000 x g for 15 min at room temperature. The concentrates were diluted in the devices with 200 ml of UA solution and centrifuged again. The concentrates were incubated with 200 ml of 20 mM DTT at room temperature for 45 min. After centrifugation as above, the concentrates were alkylated in the dark for 30 min by adding 200 ml of 50 mM iodoacetamide in UA buffer. After centrifugation at 14,000 x g for 15 min, the ultrafiltration units were washed with 200 ml of UA buffer and centrifuged at 14,000 x g for 15 min. This washing step was repeated twice. The ultrafiltration units were then washed with 200 ml of 50 mM Tris-HCl pH 8.5 and centrifuged at 14,000 x g for 15 min. This washing step was repeated twice. Proteins in the ultrafiltration units were digested overnight with 10 ng/ml of Lysyl endopeptidase (Wako) in 100 ml of 50 mM Tris-HCl pH 8.5. After incubation in a wet chamber at 37 C overnight, the digested peptides were collected in new tubes by centrifugation of the filter units at 14,000 x g for 10 min. 40 ml of 50 mM Tris-HCl was added in the ultrafiltration units and centrifuged again. The flow-through fractions were combined and acidified with 25% TFA to the final TFA concentration of 0.1%.
The digested samples were further fractionated using SCX StageTips (Kulak et al., 2014) . SCX StageTips were prepared by stacking 5 plugs of Empore SCX Disks (Sigma-Aldrich) into a 200 ml micropipette tip. The StageTips were washed with 100 ml of ACN and centrifuged at 3,600 rpm. The StageTips were then washed with 100 ml of 1% TFA and centrifuged at 3,600 rpm. This washing step was repeated twice. Then the samples were loaded onto the StageTips and centrifuged at 3,600 rpm. The flow-through was loaded onto the same StageTip again and centrifuged at 3,600 rpm. The StageTips were washed with 100 ml of 0.2% TFA and centrifuged at 3,600 rpm. This washing step was repeated twice. The peptides were collected by consecutive elution steps from SCX disks with 100 ml of 50, 100, 200, 300 and 400 mM ammonium acetate containing 20% ACN and 0.5% formic acid. The peptides remaining in the SCX disks were further eluted with 100 ml of 5% ammonium hydroxide/80% ACN. The elutates were dried in a vacuum centrifuge concentrator. The samples were further processed for desalting using C18 StageTips as described above, dried and resuspended in 10 ml of 5% formic acid for LC-MS/MS analysis.
The experiments in Figures 3E and 3F and 5A-5E were independently conducted three times.
LC-MS/MS analysis
For the identification of Vms1 interactors in Table S1 , peptides were loaded on a 15 cm column with inner diameter of 75 mm packed with 1.9 mm beads via the autosampler of the Thermo Easy LC system (Thermo Scientific). Peptides were separated and eluted using a gradient of about 120 min and sprayed directly into a benchtop Orbtitrap mass spectrometer (Q Exactive HF, Thermo Scientific). The mass spectrometer was operated in a data dependent mode with survey scans acquired at 120,000 resolution (at m/z = 200) with an AGC target of 3E6. Based on the survey scan up to 15 peptide features were selected and fragmented using HCD based fragmentation and fragmentation scans were acquired at a resolution of 15,000 (at m/z = 200). Raw data were processed using the MaxQuant 1.5.2.22 computational platform (Cox and Mann, 2008) . Peak lists generated were searched against the yeast Uniprot database with initial precursor and fragment mass tolerance of 7 and 20 ppm. Carbamidomethylation of cysteine residues was used as fixed modification with oxidation of methionine and protein N-terminal acetylation as variable modification. Proteins were quantified using the LFQ (label free quantification) algorithm (Cox et al., 2014) in-built within MaxQuant. For the identification of insoluble proteins in Table S2 and NS-mtGFP interactome in Tables S3 and S4 , chromatographic peptide separation was performed on a reverse phase column (75 mm inner diameters, New Objective) packed with Reprosil-Pur 1.9 mm C18 material (Dr.Maisch, Germany). Column temperature was maintained at 50 C by a in-house-made column oven. The peptide mixtures were analyzed by Quadrupole Orbitrap mass spectrometer (Q-Exactive HF or Q-Exactive, Thermo Fisher Scientific, Rockford, II, USA) coupled to an EASY-nLC 1200 or an EASY-nLC 1000 UHPLC system (Thermo Fisher Scientific) via a nano electrospray source. 7 ml of the samples were loaded in buffer A (0.1% formic acid) and separated with a 130 min gradient of 5%-30% buffer B (80% ACN and 0.1% formic acid) at a flowrate of 300 nl/min. The Q-Exactive HF or Q-Exactive was operated in data-dependent mode with survey acquired at mass range of 300 to 1650 m/z and a resolution setting of 60,000 or 70,000 (FWHM). Up to the seven most abundant isotope patterns from the survey scan were selected and fragmented by higher energy collisional dissociation. MS/ MS spectra were acquired with a resolution of 15,000 or 17,500 (FWHM). A maximum injection times of 50 or 120 ms, and a target value of 1e5 or 2e5 charges.
Determination of SILAC Ratios
Proteins were identified and quantified by MaxQuant software 1.3.0.5 (for Table S2 ) and MaxQuant software 1.5.0.25 (for Tables S3  and S4) (Cox and Mann, 2008) using default settings against a database of UNIPROT Saccharomyces cerevisiae (version 2014-04). Searches were run for LysC/P with a maximum of two missed cleavage sites. Carbamidomethylation was set as fixed modifications while methionine oxidation and N-terminal acetylation were as variable modifications. ''Re-quantify'' was enabled. Maxquant uses a decoy version of the specified UNIPROT database to adjust the false discovery rates for both proteins and peptides to below 1%.
Filter trap assay Total cell lysates prepared for ''Immuno-purification of NS-proteins'' were either diluted with an equal volume of SDS buffer (4% SDS, 100 mM DTT) or lysis buffer. SDS treated samples were heated for 3 min at 95 C. All samples were filtered through a cellulose acetate membrane (0.2 mm pore size) sealed within a dot blot device and subjected to vacuum filtration (Scherzinger et al., 1997) . Protein aggregates retained on the membrane were analyzed as follows. The cellulose acetate membrane was washed with TBST and blocked with 2% milk in TBST for 1 hr at room-temperature. The membrane was incubated with anti-GFP antibody in TBST overnight at 4 C and washed 5 times with TBST (5 min for each wash). The membrane was then incubated with HRP-conjugated antibody for 1 hr at room-temperature and washed again 5 times as above. ECL Plus Western Blotting Substrate (Thermo Scientific) was used as substrate of HRP. ImageQuant LAS 4000 mini (GE Healthcare) was used for signal detection. Image was analyzed using AIDA software.
The experiment in Figure 4F was independently conducted three times, the experiment in Figure S4F twice and the experiment in Figure S5A once.
Sucrose density gradient analysis
Sucrose density gradients were prepared in 50 mM Tris-HCl pH 7.4, 20 mM KCl and 10 mM MgCl 2. To generate the five-step 10%-30% gradient in Figure S1 , 500 ml of 30% sucrose solution was pipetted to an Ultra-Clear Centrifuge Tubes (13 3 51 mm, Beckman #344057), which was overlaid sequentially with 1 mL of 25%, 20%, 15% and 10% sucrose. Similarly, to generate the seven-step 10%-40% gradients in Figure 6C and S5E, 500 ml of 40% sucrose was overlaid sequentially with 500 ml of 35%, 30%, 25%, 20%, 15% and 10% sucrose. The lysates from 200 OD 600 cells were centrifuged at 20,000 x g for 10 min at 4 C and the resulting supernatants were loaded onto the gradients. The gradients were centrifuged at 40,000 rpm for 90 min at 4 C in a SW50.1 rotor (Beckman) and fractionated using a piston gradient fractionator coupled to an A 254 spectrometer (Biocomp) for Figure S1 or by pipetting 300 ml each for Figures 6C and S5E. Fractions were brought to a volume of 1 mL with ice-cold water, mixed with 150 ml of 50% TCA and incubated for 10 min on ice. The precipitates were centrifuged at 17,000 x g for 10 min at 4 C and the pellets were washed with 700 ml of ice-cold acetone. After removal of acetone, the pellets were air-dried and solubilized in 100 ml of HU buffer. Proteins were analyzed by SDS-PAGE and immunoblotting.
Fluorescence microscopy
Yeast cells grown at 30 C in SCRaf medium were shifted to SCRaf/Gal medium to induce the expression of NS-mtGFP for 5-6 hr. 5 ml of cell culture was spotted on a microscope slide and covered with a coverslip. Fluorescent imaging of living cells was performed using a Zeiss Z1 Axio Observer microscopy with Objective Plan-Apochromat 63x/1.4 Oil M27 (Zeiss). NS-mtGFP images were acquired at 40% light source intensity and 1.1 s exposure time for the 488-nm excitation. Mt-mCherry images were acquired for the 548-nm excitation and brightness and contrast were adjusted to show the overlap of mt-mCherry and NS-mtGFP signals using the imaging software ZEN 2 (blue edition) (Zeiss). For Figure S4B , the intensities of NS-mtGFP in ltn1D and vms1Dltn1D cells were adjusted to a lower level using Adobe Photoshop CS6 to compensate for their strong intensities compared to that of WT cells. The images of NS-mtGFP and mt-mCherry were merged using ZEN 2 (blue edition).
The experiments in Figure 6B were independently conducted three times and the experiments in Figure S4B twice.
QUANTIFICATION AND STATISTICAL ANALYSIS
The relative levels of Rip1 in Figure S5B were quantified using Image Studio Lite (LI-COR). Error bars represent standard deviation (SD) from four (for NS-mtGFP) and three (for NS-Shm1) independent experiments. p values were calculated by Student's t test. In Figure 6B , n represents the number of cells and error bars represent SD from three independent experiments. p-Values were calculated by Student's t test.
P values for volcano plots in Figures 1B and 6F were calculated by Student's t test for proteins which were detected by LS-MS/MS in both of two biological repeats.
In Table S1 , fold enrichment values represent the mean of two biological repeats. Listed are proteins that are enriched R 2-fold in both of two biological repeats.
In Table S2 , fold enrichment values for insoluble, soluble and total fractions represent the median of 3 biological repeats with swapped SILAC labeling to eliminate the bias of labeling media. Listed are proteins that are enriched R 2-fold in the insoluble fraction in at least two out of three experiments.
In Tables S3 and S4 , fold enrichment values represent the median of 3 biological repeats with swapped SILAC labeling to eliminate the bias of labeling media. Proteins with the recovery of at least three peptides in at least two out of three experiments were analyzed. Listed are proteins that are enriched R 3-fold in at least two out of three experiments. The proteins that were not listed formally but analyzed as references were also listed below the red line.
DATA AND SOFTWARE AVAILABILITY
The accession number for the Immunoblot data reported in this paper is Mendeley Data: (DOI: https://doi.org/10.17632/ scr4ts98gx.1). The accession number for the proteome data reported in this paper is ProteomeXchange: PXD007800 (Vizcaíno et al., 2013) . Figure S1 . Vms1 Associates with 60S Ribosomes, Related to Figure 1 Lysates from cells expressing Vms1-3Myc from its own promoter (grown in SCD medium) were subjected to 10%-30% sucrose density gradient centrifugation. Fractions were analyzed by SDS-PAGE and immunoblotting using antibodies against the Myc-tag of Vms1 and Rpl3 (subunit of the 60S ribosome). Absorbance at 254 nm and Rpl3 indicate the positions of 40S, 60S, and 80S ribosomes. T, top and B, bottom of gradient. Solubility of Hsp70 chaperone proteins in the cytosol (Ssa1) and ER (BiP) as well as of cytosolic phophoglycerate kinase (Pgk1) in WT and mutant cells from Figure 3B . Cells were grown in YPGal medium at 37 C and lysates prepared in buffer containing 0.5% Triton X-100. Total lysates (T) were separated into insoluble pellet (P) and soluble supernatant (S) fraction by centrifugation (15 min at 20,000 x g), followed by immunoblotting using the antibodies indicated. 10% of total and soluble fractions and 100% of pellet fractions were analyzed. (legend continued on next page) Figure S5 . Vms1 Counteracts Rqc2-Dependent Aggregation of NS Proteins in Mitochondria, Related to Figure 6 (A) Overexpression of Vms1 in ltn1D cells markedly reduces aggregation of NS-mtGFP as analyzed by filter trap assay. Ltn1D cells expressing NS-cGFP or NS-mtGFP from the GAL1 promoter were grown at 30 C with or without co-expression of Vms1-3Myc from the GPD1 promoter. Cell lysates were subjected to filter trap analysis in the presence or absence of SDS as in Figure 4F . (B) Vms1 overexpression in ltn1D cells expressing mitochondrial NS-proteins reduces accumulation of i-Rip1. Ltn1D cells harboring empty vector or expressing either NS-mtGFP or NS-Shm1 were grown in SCGal medium at 37 C with or without co-expression of Vms1 from the GPD1 promoter. Cell extracts were analyzed by SDS-PAGE and immunoblotting (IB) with anti-Rip1 antibodies. Levels of i-Rip1 related to total Rip1 (i-Rip1 + m-Rip1) were quantified by densitometry. Error bars represent SD from four (for NS-mtGFP) and three (for NS-Shm1) independent experiments. p values from Student's t test. (C) Vms1 overexpression partially rescues the growth defect of ltn1D cells expressing mitochondrial NS-proteins. Cells in (B) were grown on SCD plates at 37 C and analyzed as in Figure 2A . (D) Overexpression of Vms1 reduces Rqc2-dependent CAT-tailing of NS-mtGFP. Ltn1D and ltn1Drqc2D cells expressing NS-mtGFP from the GPD1 promoter were grown in SCGal medium at 37 C with or without overexpression of Vms1-3Myc from the GPD1 promoter. Total cell extracts were subjected to SDS-PAGE and IB with anti-GFP antibody. Bracket, SDS-resistant high molecular aggregates. Arrow, monomeric CAT-tailed NS-mtGFP. In order to resolve monomeric CAT-tailed NS-mtGFP, an NS-mtGFP construct with a CYC1 3 0 UTR was used.
Supplemental Figures
(E) Rqc2 deletion or overexpression does not alter the relative amount of Vms1 associated with 60S ribosomes. Upper panel: WT or rqc2D cells expressing Vms1-3Myc from its own promoter were grown in YPD medium at 30 C. Cells expressed Rqc2-3HA from its own promoter. Cell lysates were subjected to 10%-40% sucrose gradient centrifugation and fractions analyzed by IB for Vms1 using anti-Myc antibody. 60S and 80S ribosomes were detected using antibody against the 60S subunit Rpl3. Lower panel: The same experiment was performed with WT cells expressing Vms1-3Myc either with or without overexpression of Rqc2 (RQC2 OE). T, top and B, bottom of the gradient. (A) Vms1 lacking the VIM domain does not interact with Cdc48 in WT and ltn1D cells. Lysates of vms1D cells and vms1Dltn1D cells expressing Vms1-3HA, Vms1-3Myc or Vms1(DVIM)-3Myc from the GPD1 promoter were subjected to IP using anti-Myc antibody, followed by immunoblotting (IB) with anti-Myc and antiCdc48 antibodies. (B) Vms1(DVIM) retains activity to suppress NS-mtGFP aggregation. Ltn1D cells expressing NS-mtGFP from the GAL1 promoter with or without co-expression of Vms1-3Myc or Vms1 (DVIM)-3Myc from the GPD1 promoter were grown at 30 C. Immunoprecipitates prepared as in Figure 4B were analyzed by IB using anti-GFP antibody. (C) Vms1(DVIM) rescues the processing defect of Rip1. Cell extracts of vms1Dltn1D cells expressing either Vms1-3Myc or Vms1(DVIM)-3Myc from the VMS1 promoter and grown in SCGal medium at 37 C were analyzed by IB with anti-Rip1 antibodies.
(D) Vms1 (DVIM) rescues the growth defect of vms1Dltn1D cells under respiratory conditions. Vms1Dltn1D cells expressing Vms1-3Myc or Vms1 (DVIM)-3Myc from the GPD1 promoter were grown in SCD medium at 30 C, spotted on YPD and YPG plates and grown at 37 C as described in Figure 2A . Figure S7 . Homologs of the RQC2 Gene Are Present in Archaea, Related to Figure 7 Alignment of N-terminal segments of the Rqc2 proteins from various archaea and eukaryotes (source National Center for Biotechnology; https://www.ncbi.nlm. nih.gov/). Essential residues characteristic of CAT-tailing activity are highlighted in red; conserved residues throughout archaea and eukaryotes in black; structurally conserved residues in gray.
